⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12993847 | 0.83 | — | — | |
| SCHEMBL8582243 | 0.69 | — | — | |
| SCHEMBL8914347 | 0.69 | — | — | |
| SCHEMBL430949 | 0.67 | — | — | |
| SCHEMBL7081970 | 0.67 | — | — | |
| SCHEMBL10105739 | 0.67 | MEN1 (0.33) | — | |
| SCHEMBL11613606 | 0.67 | MEN1 (0.33) | — | |
| SCHEMBL19348191 | 0.67 | — | — | |
| SCHEMBL149474 | 0.67 | KMT2A (0.33) | — | |
| SCHEMBL17872125 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4063 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024201393-A1 | METHODS FOR THE SYNTHESIS OF NUCLEOSIDE ANALOGUES AND NUCLEOSIDES ANALOGUES DERIVED THEREFROM | SIMON FRASER UNIVERSITY (CA) | 2024-10-03 | — | — | WO | claimed |
| US-12060334-B2 | 3-substituted phenazine derivatives as antimicrobial agents | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-08-13 | — | — | US | claimed |
| CN-118330058-A | Method for detecting nitrofuran antibiotic metabolite content and application thereof | 中国计量科学研究院 | 2024-07-12 | — | — | CN | claimed |
| US-11963906-B2 | Devices and methods for flow control of ophthalmic formulations | TearClear Corp. (US) | 2024-04-23 | — | — | US | claimed |
| EP-3715346-B1 | THIAZOLYL-CONTAINING COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | DANA FARBER CANCER INST INC (US) | 2024-01-03 | — | — | EP | claimed |
| WO-2023201315-A2 | OPHTHALMIC AGENT IN PRESERVATIVE REMOVAL DEVICE | TearClear Corp. (US) | 2023-10-19 | — | — | WO | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| US-20230263659-A1 | DEVICES AND METHODS FOR FLOW CONTROL OF OPHTHALMIC FORMULATIONS | TearClear Corp. | 2023-08-24 | — | — | US | claimed |
| CN-116322597-A | Systems and methods for preservative removal in ophthalmic formulations | 特清公司 | 2023-06-23 | — | — | CN | claimed |
| US-11564832-B2 | Device and methods for flow control of ophthalmic formulations | TearClear Corp. (US) | 2023-01-31 | — | — | US | claimed |
| US-10711036-B2 | MALT1 inhibitors and uses thereof | CORNELL UNIVERSITY (US) | 2020-07-14 | — | — | US | claimed |
| EP-2016044-B1 | PENTACYCLINE DERIVATIVES FOR THE TREATMENT OF INFECTIONS | HARVARD COLLEGE (US) | 2020-06-10 | — | — | EP | claimed |
| EP-3209648-B1 | THIAZOLYL-CONTAINING COMPOUNDS FOR TREATING PROLIFERATIVE DISEASES | DANA FARBER CANCER INST INC (US) | 2020-03-11 | — | — | EP | claimed |
| CN-104718202-B | The method for being used to prepare (S) -3- (4- ((4- (morpholinyl methyl) benzyl) oxygroup) -1- oxoisoindolines -2- base) piperidine-2,6-diones and its pharmaceutically acceptable form | 细胞基因公司 | 2018-11-20 | — | — | CN | claimed |
| US-10112957-B2 | Thiazolyl-containing compounds for treating proliferative diseases | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2018-10-30 | — | — | US | claimed |
| EP-2550285-B1 | TRIOXACARCINS AND USES THEREOF | HARVARD COLLEGE (US) | 2017-07-19 | — | — | EP | claimed |
| EP-3074415-A1 | NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES | Agency For Science, Technology And Research (SG) | 2016-10-05 | — | — | EP | claimed |
| US-20150376201-A1 | CORTISTATIN ANALOGUES AND SYNTHESES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-12-31 | — | — | US | claimed |
| CN-104718202-A | Processes for the preparation of (S)-3-4-((4-(morpholinomethyl) benzyl)oxy)-1-oxoisoindolin-2-yl) piperidine-2,6-dione and pharmaceutically acceptable forms thereof | CELGENE CORP | 2015-06-17 | — | — | CN | claimed |
| WO-2015080670-A1 | NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-06-04 | — | — | WO | claimed |